Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katrina J. Holly"'
Publikováno v:
Frontiers in Antibiotics, Vol 3 (2024)
Recent reports from the Centers for Disease Control and Prevention approximate 500,000 cases of Lyme disease in the United States yearly, a significant economic burden on the healthcare system. The standard treatment for Lyme disease includes broad-s
Externí odkaz:
https://doaj.org/article/e7c19b1e769640bc9794373d4107b88f
Autor:
Weiwei An, Katrina J. Holly, Alessio Nocentini, Ryan D. Imhoff, Chad. S. Hewitt, Nader S. Abutaleb, Xufeng Cao, Mohamed N. Seleem, Claudiu T. Supuran, Daniel P. Flaherty
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 1838-1844 (2022)
Vancomycin-resistant enterococci (VRE), consisting of pathogenic Enterococcus faecalis and E. faecium, is a leading cause of hospital-acquired infections (HAIs). We recently repurposed the FDA-approved human carbonic anhydrase (CA) inhibitor acetazol
Externí odkaz:
https://doaj.org/article/289046e46d9a42fe9840d656ae4ed36e
Autor:
Amanda L. Graboski, Xufeng Cao, Yehia Elgammal, Devon P. Amos, Molly S. Youse, Alessio Nocentini, Nader S. Abutaleb, Anil Kumar Marapaka, Weiwei An, Mohamed N. Seleem, Claudiu T. Supuran, Ahmed E. M. Elhassanny, Katrina J. Holly, Chad S. Hewitt, Daniel P. Flaherty, Jatinder Kaur, Aaron D Krabill, Ahmed Elkashif
Publikováno v:
ACS Infectious Diseases. 7:1969-1984
Neisseria gonorrhoeae is an urgent threat to public health in the United States and around the world. Many of the current classes of antibiotics to treat N. gonorrhoeae infection are quickly becoming obsolete due to increased rates of resistance. Thu
Autor:
Chad S, Hewitt, Nader S, Abutaleb, Ahmed E M, Elhassanny, Alessio, Nocentini, Xufeng, Cao, Devon P, Amos, Molly S, Youse, Katrina J, Holly, Anil Kumar, Marapaka, Weiwei, An, Jatinder, Kaur, Aaron D, Krabill, Ahmed, Elkashif, Yehia, Elgammal, Amanda L, Graboski, Claudiu T, Supuran, Mohamed N, Seleem, Daniel P, Flaherty
Publikováno v:
ACS Infect Dis
Neisseria gonorrhoeae is an urgent threat to public health in the United States and around the world. Many of the current classes of antibiotics to treat N. gonorrhoeae infection are quickly becoming obsolete due to increased rates of resistance. Thu